The Musella Foundation is pleased to announce that we are adding two medications - vincristine and procarbazine -to our Brain Tumor Copayment Assistance Program, expanding financial support for patients facing the cost of brain tumor treatment.

 

Already have an active grant? You can submit claims for these medications retroactively to the start date of your grant. If you have paid for vincristine or procarbazine during your current grant period, you may be eligible for reimbursement.

 

For program details and to apply, visit https://braintumorcopays.org.

 

Please share this news with patients, caregivers, and healthcare teams who may benefit!